A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP)

Clinical trial NCT06785116 · RECRUITING

Trial details

NCT number: NCT06785116
Sponsor: University of Michigan
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Gestational Hypertension Hypertension in Pregnancy Pre-Eclampsia Superimposed Pre-Eclampsia Cardiovascular Complication

Start date: 2025-03-02
Primary completion: 2028-08-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.